---
title: Neuroblastoma Predisposition and Surveillance-An Update from the 2023 AACR
  Childhood Cancer Predisposition Workshop
date: '2024-06-11'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38860978/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240611181022&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: Genetic predisposition to neuroblastoma (NB) is relatively rare. Only
  1% to 2% of patients have a family history of NB, 3% to 4% of cases present with
  bilateral or multifocal primary tumors, and occasional patients have syndromes that
  are associated with increased NB risk. Previously, a germline pathogenic variant
  (GPV) in PHOX2B was associated with Hirschsprung disease and congenital central
  hypoventilation syndrome. Recently, certain GPVs were shown to be responsible for
  congenital ...
disable_comments: true
---
Genetic predisposition to neuroblastoma (NB) is relatively rare. Only 1% to 2% of patients have a family history of NB, 3% to 4% of cases present with bilateral or multifocal primary tumors, and occasional patients have syndromes that are associated with increased NB risk. Previously, a germline pathogenic variant (GPV) in PHOX2B was associated with Hirschsprung disease and congenital central hypoventilation syndrome. Recently, certain GPVs were shown to be responsible for congenital ...